Illumina competitors

Illumina's competitors include Synthetic Genomics, ARCA biopharma, Orphazyme and CRISPR Therapeutics
Add company...
Illumina
Illumina is a global company that develops innovative array-based solutions for DNA, RNA, and protein analysis.
Synthetic Genomics
Synthetic Genomics is a synthetic biology company that develops and commercializes genomic-driven technologies for various industries.
ARCA biopharma
ARCA biopharma develops genetically-targeted therapies for cardiovascular diseases.
Orphazyme
Orphazyme develops therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases.
CRISPR Therapeutics
CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.
Founding Date
Founding Date
1998
Founding Date
2005
Founding Date
2009
Founding Date
2009
Founding Date
2013
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Scoresby, AU
São Paulo, BR
Victoria, CA
Shanghai, CN
Beijing, CN
Minato, JP
see more
Locations
La Jolla, US HQ
Locations
Westminster, US HQ
Aurora, US
Westminster, US
Locations
København, DK HQ
Newton, US
Locations
Zug, CH HQ
Greater London, GB
Cambridge, US
Employees
Employees
6,20013% increase
Employees
18910% decrease
Employees
20
Employees
34
Employees
93
Valuation ($)
Valuation ($)
51.9 b
Valuation ($)
N/A
Valuation ($)
7.4 m
Valuation ($)
N/A
Valuation ($)
2.6 b
Facebook likes
Facebook likes
15.4 k
Facebook likes
3.7 k
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
N/A
Twitter followers
Twitter followers
57 k
Twitter followers
2.8 k
Twitter followers
N/A
Twitter followers
N/A
Twitter followers
3.5 k

Financial

Net income
Net income
$428.1m (FY, 2017)
Net income
N/A
Net income
($18.5m) (FY, 2017)
Net income
N/A
Net income
($68.4m) (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 40m
Total funding raised
$ 7.2m
Total funding raised
$ 58.8m
Total funding raised
$ 127m
For sources of this data, please see the company profileDownload Excel

View company profiles

Synthetic Genomics
HQ
La Jolla, US
Employees
189↓ 10% decrease

Synthetic Genomics is a synthetic biology company that develops and commercializes genomic-driven technologies for various industries.

View company
ARCA biopharma
HQ
Westminster, US
Employees
20

ARCA biopharma develops genetically-targeted therapies for cardiovascular diseases.

View company
Orphazyme
HQ
København, DK
Employees
34

Orphazyme develops therapies for the treatment of a family of serious genetic disorders called lysosomal storage diseases.

View company
CRISPR Therapeutics
HQ
Zug, CH
Employees
93

CRISPR Therapeutics is a gene editing company focused on developing transformative gene-based medicines for the treatment of serious human diseases.

View company